FeesSafety
Pluang+

Hinge Health upgrades to Buy as Q3 revenue jumps 52% and profit forecasts rise.

Analyst Insights
19 Nov 2026, 18:15 WIB
Seeking Alpha
View Source
Bullish
Hinge Health upgrades to Buy as Q3 revenue jumps 52% and profit forecasts rise.

Hinge Health, Inc. has been upgraded from Hold to Buy due to strong Q3 results and improved future outlook. The company reported a 52% revenue increase to $235 million and a non-GAAP operating margin of 33%, with record free cash flow of $112.7 million. It also raised its 2026 revenue midpoint to $880 million and operating profit guidance to $266–268 million, driven by client and program growth. Despite its high valuation, the positive growth and profitability improvements support a more optimistic long-term investment view.

As of Nov 19, 2026 23:31 WIB, Hinge Health Inc. Class A Common Stock (HNGE) trades at USD 110.71 on Pluang, down 3.34% for the day. The stock has a market cap of $9.31 billion and an enterprise value of $9.05 billion. Despite the recent price dip, the company’s strong Q3 results and raised guidance may influence investor sentiment going forward.

banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App